Author:
Pielken H.-J.,Urbanitz D.,Büchner Th.,Koch P.,Hiddemann W.,van de Loo J.
Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Al-Rammahy AK, Shipman S, Jackson A, Malcom A, Levy JG (1980) Evidence for common leukemia-associated antigen in acute myelogenous leukemia. Cancer Immunol Immunother 9: 181–185
2. Baldwin MA, Robins RA (1978) Factors interferring with immunological rejection of tumors. Br Med Bull 32: 118–123
3. Bates JG, Suen JY, Tranum BL (1979) Immunological skin testing and interpretation. A plea for uniformity. Cancer 43: 2306–2314
4. Bekesi JG, Arneault GST, Walter L, Holland JF (1972) Immunogenicity of Leukemia L1210 cells after neuraminidase treatment. J. Natl Cancer Inst 49: 107–118
5. Bekesi JG, Holland JF, Flemminger R, Yates J, Henderson ES (1977) Immunotherapeutic efficacy of neuraminidase-treated allogeneic myeloblasts in patients with acute myelocytic leukemia. In: Chirigos MA (ed) Control of Neoplasia by modulation of the Immune System, pp 573-592